Dr Cathy Quinlan
Dr Cathy Quinlan is a Consultant Paediatric Nephrologist in The Royal Children's Hospital and Honorary Research Fellow at the Murdoch Childrens Research Institute. A graduate of University College Dublin, she completed her clinical training in the Children's University Hospital in Dublin and Great Ormond Street Hospital in London.
She completed research towards an MSc in Medical Education in Queens University Belfast and MD(Res) in University College London investigating the cardiovascular phenotype in juvenile-onset lupus before moving to the Melbourne Children's Campus in 2013.
Her research interests include inherited kidney disease, cardiovascular disease in kidney disease, nephrotic syndrome, cystic fibrosis renal disease and peritoneal dialysis.
- Consultant Paediatric Nephrologist, Nephrology Department, The Royal Children's Hospital
Dr Quinlan's research interests focus on
- Genetic basis of kidney disease
- Long term sequelae of childhood nephrotic syndrome
- Optimising peritoneal dialysis
- Cardiovascular disease in kidney disease
- Investigation of genetic renal disease in RCH
- Vascular risk phenotypes after childhood nephrotic syndrome
- Establishing Predictive Indicators of Aminoglycoside Nephrotoxicity and the incidence of Ototoxicity in children aged <6 years with Cystic Fibrosis (PIANO-CF)
- Optimising Peritoneal Dialysis: A Comparison of Adapted and Conventional Peritoneal Dialysis
Cardiovascular morbidity in juvenile-onset systemic lupus erythematosus. Quinlan C, Kari J, Pilkington C, Deanfield J, Shroff R, Marks SD, Tullus K. Accepted for publication by Paediatr Nephrol
Use of neutrophil gelatinase-associated lipocalin (NGAL) in CF. Munro C, Ranganathan S, Coulthard K, Quinlan C. J Cyst Fibros. 2015 Jan;14(1):154.
Chronic hemodialysis in children weighing less than 10 kg. Quinlan C, Bates M, Sheils A, Dolan N, Riordan M, Awan A. Pediatr Nephrol. 2013 May;28(5):803-9.
Tinzaparin is safe and effective in the management of hemodialysis catheter thrombosis. Quinlan C, Bates M, Cotter M, Riordan M, Waldron M, Awan A. ASAIO J. 2012 May-Jun;58(3):288-90.
Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment. Quinlan C, Guegan K, Offiah A, Neill RO, Hiorns MP, Ellard S, Bockenhauer D, Hoff WV, Waters AM. Pediatr Nephrol. 2012 Apr;27(4):581-8
Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation? Shroff R, Quinlan C, Mitsnefes M. Pediatr Nephrol. 2011 Jun;26(6):853-65.
Pediatric renal transplantation in a highly sensitised child-8 years on. Quinlan C, Awan A, Gill D, Waldron M, Little D, Hickey D, Conlon P, Keogan M. Case Rep Transplant. 2011;2011:370596.
Eosinophilic peritonitis in children on chronic peritoneal dialysis. Quinlan C, Cantwell M, Rees L. Pediatr Nephrol. 2010 Mar;25(3):517-22.
A big boy with proteinuria. Focal and segmental glomerulosclerosis. Quinlan C, Dorman T, Gill D. Pediatr Nephrol. 2008 Dec;23(12):2175-8.
Cyanide poisoning in the post-transplantation patient-a cautionary tale. Quinlan C, Gill D, Waldron M, Awan A. Pediatr Nephrol. 2008 Dec;23(12):2273-5.